111 related articles for article (PubMed ID: 2433727)
41. Production of hepatitis B virus surface antigen particles by the human hepatoma cell line huGK-14 in a serum-free medium.
Koike K; Yoshida E; Katagiri K; Katayanagi M; Oda M; Tsunoo H; Yaginuma K; Kobayashi M
Jpn J Cancer Res; 1987 Dec; 78(12):1341-6. PubMed ID: 2828295
[TBL] [Abstract][Full Text] [Related]
42. Specific expression of human interferon-gamma controls hepatitis B virus replication in vitro in secreting hepatitis B surface antigen hepatocytes.
Kan Q; Li D; Yu Z
J Virol Methods; 2012 Mar; 180(1-2):84-90. PubMed ID: 22240074
[TBL] [Abstract][Full Text] [Related]
43. Inhibition of hepatitis B virus DNA replicative intermediate forms by recombinant interferon-gamma.
Parvez MK; Sehgal D; Sarin SK; Basir SF; Jameel S
World J Gastroenterol; 2006 May; 12(19):3006-14. PubMed ID: 16718779
[TBL] [Abstract][Full Text] [Related]
44. CpG oligodeoxynucleotide inhibits HBV replication in a hydrodynamic injection murine model.
Hu W; Huang H; Zhang TY; Mao YY; Wang XJ; Wang SQ
Antivir Ther; 2015; 20(3):289-95. PubMed ID: 25279542
[TBL] [Abstract][Full Text] [Related]
45. Interaction of interferon-alpha with interleukin-1 beta or tumor necrosis factor-alpha on hepatitis B virus enhancer activity.
Hamasaki K; Nakata K; Nakao K; Mitsuoka S; Tsutsumi T; Kato Y; Shima M; Ishii N; Tamaoki T; Nagataki S
Biochem Biophys Res Commun; 1992 Mar; 183(2):904-9. PubMed ID: 1312844
[TBL] [Abstract][Full Text] [Related]
46. Detection of hepatitis B virus DNA directly in human serum by a simplified molecular hybridization test: comparison to HBeAg/anti-HBe status in HBsAg carriers.
Lieberman HM; LaBrecque DR; Kew MC; Hadziyannis SJ; Shafritz DA
Hepatology; 1983; 3(3):285-91. PubMed ID: 6301965
[TBL] [Abstract][Full Text] [Related]
47. Cytokine inhibition of the hepatitis B virus core promoter.
Romero R; Lavine JE
Hepatology; 1996 Jan; 23(1):17-23. PubMed ID: 8550037
[TBL] [Abstract][Full Text] [Related]
48. Individualized treatment of HBeAg-negative chronic hepatitis B using pegylated interferon-α2a as first-line and week-12 HBV DNA/HBsAg stopping rule: a cost-effectiveness analysis.
Iannazzo S; Coco B; Brunetto MR; Rossetti F; Caputo A; Latour A; Espinos B; Bonino F
Antivir Ther; 2013; 18(4):623-33. PubMed ID: 23486701
[TBL] [Abstract][Full Text] [Related]
49. Hepatitis B surface antigen produced by a human hepatoma cell line.
MacNab GM; Alexander JJ; Lecatsas G; Bey EM; Urbanowicz JM
Br J Cancer; 1976 Nov; 34(5):509-15. PubMed ID: 187208
[TBL] [Abstract][Full Text] [Related]
50. High rates of HBsAg seroconversion in HBeAg-positive chronic hepatitis B patients responding to interferon: a long-term follow-up study.
Moucari R; Korevaar A; Lada O; Martinot-Peignoux M; Boyer N; Mackiewicz V; Dauvergne A; Cardoso AC; Asselah T; Nicolas-Chanoine MH; Vidaud M; Valla D; Bedossa P; Marcellin P
J Hepatol; 2009 Jun; 50(6):1084-92. PubMed ID: 19376603
[TBL] [Abstract][Full Text] [Related]
51. Different expression of hepatitis B surface antigen between hepatocellular carcinoma and its surrounding liver tissue, studied using a tissue microarray.
Wang Y; Wu MC; Sham JS; Tai LS; Fang Y; Wu WQ; Xie D; Guan XY
J Pathol; 2002 Aug; 197(5):610-6. PubMed ID: 12210080
[TBL] [Abstract][Full Text] [Related]
52. Induction of antiviral cytidine deaminases does not explain the inhibition of hepatitis B virus replication by interferons.
Jost S; Turelli P; Mangeat B; Protzer U; Trono D
J Virol; 2007 Oct; 81(19):10588-96. PubMed ID: 17652382
[TBL] [Abstract][Full Text] [Related]
53. Immunomodulatory and antiproliferative effect of recombinant alpha, beta, and gamma interferons on cultured human malignant squamous cell lines, SCL-1 and SW-1271.
Nickoloff BJ; Basham TY; Merigan TC; Morhenn VB
J Invest Dermatol; 1985 Jun; 84(6):487-90. PubMed ID: 3923127
[TBL] [Abstract][Full Text] [Related]
54. Stable expression and integrated hepatitis B virus genome in a human hepatoma cell line.
Wang LY; Li YG; Chen K; Li K; Qu JL; Qin DD; Tang H
Genet Mol Res; 2012 May; 11(2):1442-8. PubMed ID: 22653591
[TBL] [Abstract][Full Text] [Related]
55. Production of hepatitis B virus by a differentiated human hepatoma cell line after transfection with cloned circular HBV DNA.
Sureau C; Romet-Lemonne JL; Mullins JI; Essex M
Cell; 1986 Oct; 47(1):37-47. PubMed ID: 3019565
[TBL] [Abstract][Full Text] [Related]
56. Enhanced expression of HLA class I by inhibited replication of hepatitis B virus.
Takehara T; Hayashi N; Katayama K; Ueda K; Towata T; Kasahara A; Fusamoto H; Kamada T
J Hepatol; 1992 Mar; 14(2-3):232-6. PubMed ID: 1323597
[TBL] [Abstract][Full Text] [Related]
57. Molecular cloning and characterization of the cDNA coding for hepatitis B virus surface antigen.
He BG; Melnick JL; Siddiqui A; Robinson WS; Law SW; Lai EC
Sci Sin B; 1985 Jan; 28(1):49-59. PubMed ID: 2984765
[TBL] [Abstract][Full Text] [Related]
58. Further studies on production and characterization of HBsAg derived from a human hepatoma cell line (PLC/PRF/5).
Barin F; Goudeau A; Brechot C; Romet-Lemonne J; Sureau C; Lesage G
Dev Biol Stand; 1983; 54():81-92. PubMed ID: 6317496
[TBL] [Abstract][Full Text] [Related]
59. Identification of hepatitis B virus integration in hepatitis C virus-infected hepatocellular carcinoma tissues.
Urashima T; Saigo K; Kobayashi S; Imaseki H; Matsubara H; Koide Y; Asano T; Kondo Y; Koike K; Isono K
J Hepatol; 1997 Apr; 26(4):771-8. PubMed ID: 9126788
[TBL] [Abstract][Full Text] [Related]
60. Effects of human recombinant interferons-alpha 2, -beta and -gamma on growth and survival of human cancer nodules maintained in continuous organotypic culture.
Beaupain R; Billard C; Falcoff E
Eur J Cancer Clin Oncol; 1986 Feb; 22(2):141-9. PubMed ID: 2422038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
